South Korea Veterinary Vaccine Market Size, Share, and COVID-19 Impact Analysis, By Vaccine Type (Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines, DNA Vaccines, and Others), By Animal Type (Companion Animals, Livestock Animals, Aquatic Animals, and Others), and South Korea Veterinary Vaccine Market Insights, Industry Trend, Forecasts to 2035

South Korea Veterinary Vaccine Market Insights Forecasts to 2035

• The South Korea Veterinary Vaccine Market Size is Expected to Grow at a CAGR of around 8.7% from 2025 to 2035
• The South Korea Veterinary Vaccine Market Size is Expected to hold a significant Share by 2035

According to a research report published by Spherical Insights & Consulting, The South Korea Veterinary Vaccine Market Size is anticipated to grow at a CAGR of 8.7% from 2025 to 2035. The market is driven by increasing pet ownership, rising livestock disease control initiatives, and growing demand for safe and sustainable animal healthcare solutions.

Market Overview

The South Korea veterinary vaccine market includes the development, manufacture, and sale of vaccines designed to prevent and control infectious disease in animals. The market includes veterinary vaccines administered to both livestock and companion animals, as they are critical for animal health, food safety, and for the control of zoonotic disease transmission to humans. Increasing pet ownership in South Korea, an increasing number of livestock farms, and growing awareness of preventive healthcare for animals has strengthened the veterinarian vaccines market. Government policies aimed to control endemic outbreaks of diseases like foot-and-mouth disease and avian influenza further indicate explicit and implicit need for veterinarian immunization strategies. As a result of the increased demand for high-quality products from animal origin/animal protein, along with heightened biosecurity measures in food production, the veterinary vaccine market is consistently growing.

Report Coverage

This research report categorizes the market for the South Korea veterinary vaccine market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea veterinary vaccine market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea veterinary vaccine market.

Driving Factors

The South Korea veterinary vaccine market is driven by an increased adoption of pets, the need for safe, high-quality livestock products, and increased knowledge about preventive health care concerning animals. Local outbreaks of zoonotic diseases and livestock diseases, such as the recent strains of avian influenza and foot-and-mouth diseases, compound the need for vaccinations, which is also supported by government initiatives and funding on the health of animals.

Restraining Factors

The market faces restraints due to the high costs of developing a vaccine, arduous regulatory/translational processes, and issues associated with cold-chain storage. Maintaining informal or inconsistent cold-chains is a particular issue for smaller-scale livestock farmers, who have limited commodity awareness and ultimately have to contend with counterfeit and poor-quality alternatives reducing overall market growth.

Market Segmentation

The South Korea veterinary vaccine market share is classified into vaccine type and animal type.

• The live attenuated vaccines segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea veterinary vaccine market is segmented by vaccine type into inactivated vaccines, live attenuated vaccines, subunit vaccines, DNA vaccines, and others. Among these, the live attenuated vaccines segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to their strong immune response and duration of protection animals have to infectious diseases. They are popular to use in livestock purposes in order to effectively control disease outbreaks. Their value, essentially the cost effectiveness of the vaccine and being able to mimick a natural infection, make them desirable.

• The livestock animals segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea veterinary vaccine market is segmented by animal type into companion animals, livestock animals, aquatic animals, and others. Among these, the livestock animals segment dominated the market share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is as a result of strong livestock industry, especially, in poultry, swine, and cattle operations. Increasing consumption of meat and dairy leads to demand for effective vaccination programs. This increases demand; in addition to government agendas relating to the control of zoonotic diseases also drives growth for this segment.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea veterinary vaccine market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Zoetis Inc.
• Merck Animal Health
• Boehringer Ingelheim Animal Health
• Elanco Animal Health
• Ceva Sante Animale
• Virbac
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea veterinary vaccine market based on the below-mentioned segments

South Korea Veterinary Vaccine Market, By Vaccine Type

• Inactivated Vaccines
• Live Attenuated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Others

South Korea Veterinary Vaccine Market, By Animal Type

• Companion Animals
• Livestock Animals
• Aquatic Animals
• Others